Haemonetics
192 hedge funds and large institutions have $2.16B invested in Haemonetics in 2013 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 67 reducing their positions, and 22 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 67
2.32% more ownership
Funds ownership: 102.87% → 105.19% (+2.3%)
0% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 22
1% less capital invested
Capital invested by funds: $2.18B → $2.16B (-$27.5M)
2% less funds holding
Funds holding: 195 → 192 (-3)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $239K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$58M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$45.2M |
| 3 |
CI
Cambiar Investors
Denver,
Colorado
|
+$42.3M |
| 4 |
KI
Kalmar Investments
Greenville,
Delaware
|
+$39.6M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$14.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair & Company
Chicago,
Illinois
|
-$48.3M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$33.1M |
| 3 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
-$30M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$14M |
| 5 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$9.3M |
HAE Hedge Fund Activity: Q3 2013 in Review
192 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q3 2013, worth a combined $2.16B — down 1.3% from $2.18B a quarter earlier.
Fund positioning in HAE was balanced in Q3 2013: 22 funds opened new positions, 22 closed out, 76 added to existing stakes and 67 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $58M. The largest seller was William Blair & Company, cutting an estimated $48.3M.
- 192 institutional investors held Haemonetics (HAE) as of Q3 2013, down from 195 in Q2 2013.
- Funds reported $2.16B of Haemonetics stock for Q3 2013, down 1.3% quarter-over-quarter.
- 22 funds opened new Haemonetics positions in Q3 2013 and 22 closed out, a net change of 0 holders.
- The largest Haemonetics buyer in Q3 2013 was Capital World Investors, an estimated $58M added.
- The largest Haemonetics seller in Q3 2013 was William Blair & Company, an estimated $48.3M sold.
Based on aggregated 13F filings for Q3 2013.